QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 13, 2006--AngioDynamics, Inc., (NASDAQ:ANGO - News) today announced that it has amended its agreement with Bioniche Pharma Group Limited to expand its market to be the sole distributor of Sotradecol(TM) for the treatment of small, uncomplicated varicose veins and other vascular indications in all markets in the United States. Bioniche has agreed to use all reasonable commercial efforts to terminate its relationships with other parties who sell or distribute Sotradecol in the U.S.
